Covista Inc. Common Shares (CVSA)
Stock · NYSE · Real Estate
$126.69as of 10/16/2026
Price chart
Active signals
CVSA Signal Track Record
How signals performed across all stocks →What CVSA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 33 | +5.4% | 64% | September 18, 2026 |
| Bollinger Band Breakout | 28 | +4.3% | 64% | August 7, 2026 |
| 200-Day Moving Average TouchActive now | 21 | +5.7% | 76% | September 28, 2026 |
| Bollinger Band Breakdown | 17 | +4.7% | 59% | September 28, 2026 |
| Any 20-session window (baseline) | +2.6% | 61% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CVSA
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company provides degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education…
- Sector
- Real Estate
- Industry
- Other Consumer Services
- Employees
- 4,736
- Website
- www.covista.com
Fundamentals
- 1-day range
- $126.97$131.7
- Market cap
- $4.23B
- P/E (trailing)
- 17.31
- P/E (forward)
- 12.72
- EPS (trailing)
- $7.04
- Dividend yield
- —
- Beta
- 0.67
- Avg. volume
- 345.6K
- Ex-dividend date
- November 30, 2016
How Covista Inc. Common Shares Makes Money
Where the revenue actually goes — FY2026 annual results
Source: 10-K filed Aug 6, 2026 · via SEC EDGAR / Finnhub
Forecasts
4 analyst ratings
Covista Inc. Common Shares Competitors
Chosen by industry and closest market cap.
- CVSACovista Inc. Common Shares$126.75▼ 0.39%Market cap $4.23BP/E 17.31$86.97$156.26
- BFAMBright Horizons Family Solutions Inc. Common Stock$71.15▲ 1.04%Market cap $3.89BP/E 19.57$57.63$109.86
- LOPEGrand Canyon Education Inc. Common Stock$161.58▲ 0.09%Market cap $3.88BP/E 18.70$134.27$223.04
- LRNStride Inc. Common Stock$82.39▼ 0.95%Market cap $3.48BP/E 10.22$60.61$155.06
- GHCGraham Holdings Company Common Stock$1,203▲ 0.38%Market cap $5.06BP/E 9.20$929.76$1,262
- LAURLaureate Education Inc. Common Stock$38.61▼ 1.10%Market cap $5.14BP/E 16.96$24.98$40.93
- UNFUnifirst Corporation Common Stock$263▼ 0.69%Market cap $5.22BP/E 39.63$147.66$306.67
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CVSA Covista Inc. Common Shares | $4.23B | 17.31 | $126.75 | ▼ 0.39% | $86.97$156.26 |
| BFAM Bright Horizons Family Solutions Inc. Common Stock | $3.89B | 19.57 | $71.15 | ▲ 1.04% | $57.63$109.86 |
| LOPE Grand Canyon Education Inc. Common Stock | $3.88B | 18.70 | $161.58 | ▲ 0.09% | $134.27$223.04 |
| LRN Stride Inc. Common Stock | $3.48B | 10.22 | $82.39 | ▼ 0.95% | $60.61$155.06 |
| GHC Graham Holdings Company Common Stock | $5.06B | 9.20 | $1,203 | ▲ 0.38% | $929.76$1,262 |
| LAUR Laureate Education Inc. Common Stock | $5.14B | 16.96 | $38.61 | ▼ 1.10% | $24.98$40.93 |
| UNF Unifirst Corporation Common Stock | $5.22B | 39.63 | $263 | ▼ 0.69% | $147.66$306.67 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Full Transcript: Covista Q4 2026 Earnings Callbenzinga · 10/13/2026
- Covista (NYSE:CVSA): A GARP Case Backed by Reasonable Growth and ValuationChartMill · 10/6/2026
- 1 Profitable Stock to Target This Week and 2 We IgnoreYahoo · 10/6/2026
- 3 Reasons to Avoid CVSA and 1 Stock to Buy InsteadYahoo · 10/5/2026
- BMO Capital Maintains Outperform on Covista, Lowers Price Target to $145Benzinga · 10/5/2026
- The DAISY Foundation® Names Walden University an Extraordinary Educational PartnerYahoo · 10/1/2026
- Covista Announces First Quarter Fiscal Year 2027 Conference CallYahoo · 9/29/2026
- The Healthcare Workforce Gap Is Set to Nearly Double by 2040Yahoo · 9/28/2026
- 1 Safe-and-Steady Stock on Our Buy List and 2 Facing ChallengesYahoo · 9/18/2026
Insider Activity
Insider Actions →- Beard, Stephen W. · October 9, 2026 · Sale4.7K @ $130.77
- Beard, Stephen W. · October 8, 2026 · Sale3.6K @ $130.37
- MALAFRONTE MICHAEL W · August 31, 2026 · Gift2.5K
- Gangadharan Manjunath · August 27, 2026 · Sale1.8K @ $137.18
- Phelan Robert J. · August 23, 2026 · Grant10.1K @ $132.35
- Phelan Robert J. · August 23, 2026 · Tax Withholding3.1K @ $132.35
- Phelan Robert J. · August 23, 2026 · Grant7.1K @ $132.35
- Phelan Robert J. · August 23, 2026 · Tax Withholding1.3K @ $132.35
- BECK DOUGLAS G. · August 23, 2026 · Tax Withholding1.9K @ $132.35
- BECK DOUGLAS G. · August 23, 2026 · Grant4.2K @ $132.35
- Beard, Stephen W. · August 23, 2026 · Tax Withholding23.5K @ $132.35
- Beard, Stephen W. · August 23, 2026 · Grant53.1K @ $132.35
- Beard, Stephen W. · August 23, 2026 · Tax Withholding9.6K @ $132.35
- Betz Michael · August 23, 2026 · Tax Withholding2.3K @ $132.35
- Betz Michael · August 23, 2026 · Grant5.1K @ $132.35
Institutional Ownership
March 31, 2026
- Total shares held
- 31.51M
- Total value held
- $3.44B
- Institutional holders
- 342
- Unknown5.23M
- Unknown2.65M
- Unknown1.93M
- Unknown1.77M
- Unknown1.49M
- Unknown1.35M
- Unknown1.03M
- Unknown854.0K
- Unknown816.3K
- Unknown741.2K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Covista receives mixed analyst coverage and rating update
Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.
Covista receives mixed analyst coverage and rating update. Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.